Our results suggest a potentially adverse collaboration between Notch1 and AKT, in which the two signaling pathways are intertwined in increasing the stemness of pancreatic cancer cells upon gemcitabine chemotherapy. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.